Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, has launched its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.
The Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.
TRIMERO Diagnostics offers IVD CE marked Retinol Binding Protein assays, for serum and urine samples, available for nephelometers and the most popular Clinical Chemistry analyzers present on the market.
Powerful and comprehensive health monitoring platform now offers FDA-cleared biomarkers for pulse and respiratory rate
– Excellent accurate measurement in molarity of Lp(a) ( nmol/L ) – Alternative measurement in mass ( mg/ dL ) – Isoform-insensitive test with harmonized reagent and calibrators – Liquid-stable and ready-to-use system reagent – Standardized to international WHO-IFCC reference material SRM2B – DiaSys Lp(a) 21 FS applicable on any clinical chemistry analyzer
AliveDx receives three IVDR CE Marks for its automated, multiplexed MosaiQ® solution, enabling faster diagnosis of Connective Tissue Diseases (CTD)
The FlowLab Column from Uniqsis is an affordable flow chemistry system designed specifically for high temperature and pressure catalysis applications. At the heart of the FlowLab Column is a HotCoil heated reactor module fitted with a HotColumn adapter to enable operation up to +260 °C (300 °C as an option).
Kivo, the intuitive Document Management Solution for life sciences, has introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.
HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for Glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. HORIBA is distributing this cell function assay to the UK market following its acquisition of US-based Pointe Scientific in 2021. Used for the quantitative determination of G6PD enzyme activity in blood, the […]
Sebia, a world leader in multiple myeloma diagnostics and monitoring, has introduced M-inSight its serum-based Minimal Residual Disease (MRD) test for monitoring in multiple myeloma. M-inSight is a Laboratory Developed Test (LDT) being offered by Corgenix, part of the Sebia Group.
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.